Papers

3

Total Citations

21

H-Index

2

About

Rifat Hamoudi is a pioneering researcher at the intersection of genomics, molecular diagnostics, and artificial intelligence. His early work focused on developing high-throughput mutation detection systems, most notably the fluorescent mutation detection (F-MD) method for screening large cancer susceptibility genes like BRCA2. This improved heteroduplex analysis technique, published in 2001, enabled faster, automated screening for germline mutations, laying critical groundwork for modern genomic diagnostics. Hamoudi also advanced functional genomics by automating gene identification and cloning processes using robotic workstations, significantly accelerating the discovery of disease-causing genes. More recently, he has turned his attention to the transformative potential of artificial intelligence in medicine and medical education, exploring how AI can manage the vast data generated by modern diagnostics and treatment paradigms. His work spans from bench-top molecular biology to computational medicine, demonstrating a career-long commitment to innovation. With foundational papers cited over 20 times and a growing influence in AI-driven healthcare, Hamoudi’s contributions continue to shape how researchers and clinicians approach genetic screening, automation, and the future of medical education.

Research Focus

Key Achievements

2
H-Index
3
Papers
21
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
An improved high throughput heteroduplex mutation detection system for screeningBRCA2 mutations?fluorescent mutation detection (F-MD)
16 citations · 2001
📈 Most Prolific Year: 2001 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Institute of Cancer Research, University of Sharjah, University of London

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago